Dr. Kseniia Vlasova is a scientist at Stanford University specializing in nanomedicine, RNA delivery, and advanced drug delivery systems. Her research focuses on engineering lipid and polymer-based nanoparticles for gene therapy and vaccine applications, including the delivery of circular RNA, Cas9, and prime editors. She previously held a postdoctoral position at Oregon State University, where she led a project on pulmonary mRNA delivery. Dr. Vlasova earned her Ph.D. in Nanobiotechnology from Lomonosov Moscow State University, where she developed stimuli-responsive drug delivery systems.
Dr. Kseniia Vlasova is a scientist at Stanford University specializing in nanomedicine, RNA delivery, and advanced drug delivery systems. Her research focuses on engineering lipid and polymer-based nanoparticles for gene therapy and vaccine applications, including the delivery of circular RNA, Cas9, and prime editors. She previously held a postdoctoral position at Oregon State University, where she led a project on pulmonary mRNA delivery. Dr. Vlasova earned her Ph.D. in Nanobiotechnology from Lomonosov Moscow State University, where she developed stimuli-responsive drug delivery systems.
Dr. Kseniia Vlasova is a scientist at Stanford University specializing in nanomedicine, RNA delivery, and advanced drug delivery systems. Her research focuses on engineering lipid and polymer-based nanoparticles for gene therapy and vaccine applications, including the delivery of circular RNA, Cas9, and prime editors. She previously held a postdoctoral position at Oregon State University, where she led a project on pulmonary mRNA delivery. Dr. Vlasova earned her Ph.D. in Nanobiotechnology from Lomonosov Moscow State University, where she developed stimuli-responsive drug delivery systems.